RSSIn Focus

Topical Ivermectin: Data Supporting Dual Modes of Action in Rosacea

Topical Ivermectin: Data Supporting Dual Modes of Action in Rosacea

| September 1, 2017

by James Q. Del Rosso, DO, FAOCD, FAAD Dr. Del Rosso is Research Director at JDR Dermatology Research in Las Vegas, Nevada; Adjunct Clinical Professor of Dermatology at Touro University Nevada, Las Vegas; and with Dermatology and Cutaneous Surgery at Thomas Dermatology in Las Vegas, Nevada. Funding: The author did not receive any form of […]

Continue Reading

Topical Alpha-Agonist Therapy for Persistent Facial Erythema of Rosacea and the Addition of Oxmetazoline to the Treatment Armamentarium: Where Are We Now?

Topical Alpha-Agonist Therapy for Persistent Facial Erythema of Rosacea and the Addition of Oxmetazoline to the Treatment Armamentarium: Where Are We Now?

| July 1, 2017

by James Q. Del Rosso, DO, FAOCD, FAAD Dr. Del Rosso is Research Director at JDR Dermatology Research, Las Vegas, Nevada and at Henderson Dermatology Research in Henderson, Nevada; is Adjunct Clinical Professor (Dermatology) at ableouro University Nevada, Las Vegas, Nevada; and practices Dermatology and Cutaneous Surgery at Thomas Dermatology in Las Vegas, Nevada. J […]

Continue Reading